Zhaobing Ding

1.2k total citations
23 papers, 866 citations indexed

About

Zhaobing Ding is a scholar working on Molecular Biology, Clinical Biochemistry and Cancer Research. According to data from OpenAlex, Zhaobing Ding has authored 23 papers receiving a total of 866 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Clinical Biochemistry and 7 papers in Cancer Research. Recurrent topics in Zhaobing Ding's work include Cancer, Hypoxia, and Metabolism (7 papers), Metabolism and Genetic Disorders (7 papers) and Virus-based gene therapy research (4 papers). Zhaobing Ding is often cited by papers focused on Cancer, Hypoxia, and Metabolism (7 papers), Metabolism and Genetic Disorders (7 papers) and Virus-based gene therapy research (4 papers). Zhaobing Ding collaborates with scholars based in Singapore, Switzerland and United States. Zhaobing Ding's co-authors include Beat Thöny, Weiping Han, Russell Ericksen, Han Chong Toh, P Georgiev, Beat Thöny, Aurora Martı́nez, Cary O. Harding, Timothy Wai Ho Shuen and Eric Kubli and has published in prestigious journals such as Cell Metabolism, Cancer Research and FEBS Letters.

In The Last Decade

Zhaobing Ding

23 papers receiving 856 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhaobing Ding Singapore 16 538 221 179 171 115 23 866
Łukasz Opaliński Poland 23 1.2k 2.2× 128 0.6× 90 0.5× 51 0.3× 70 0.6× 57 1.4k
Brenda Kostelecky United Kingdom 11 1.2k 2.2× 177 0.8× 92 0.5× 50 0.3× 184 1.6× 11 1.4k
Jiuya He United Kingdom 20 1.7k 3.1× 428 1.9× 79 0.4× 154 0.9× 99 0.9× 26 1.8k
Frauke Leenders Germany 17 701 1.3× 139 0.6× 90 0.5× 280 1.6× 45 0.4× 26 1.1k
Stephan Schlenker Germany 7 1.5k 2.8× 95 0.4× 88 0.5× 188 1.1× 157 1.4× 7 1.8k
Annett Koch Germany 17 1.4k 2.7× 97 0.4× 82 0.5× 102 0.6× 158 1.4× 17 1.7k
Stefan J. Siira Australia 18 893 1.7× 150 0.7× 89 0.5× 53 0.3× 48 0.4× 29 989
Noel Edwards United Kingdom 18 399 0.7× 41 0.2× 48 0.3× 120 0.7× 31 0.3× 28 785
Mickaël M. Cohen France 16 1.2k 2.3× 125 0.6× 36 0.2× 72 0.4× 81 0.7× 27 1.4k

Countries citing papers authored by Zhaobing Ding

Since Specialization
Citations

This map shows the geographic impact of Zhaobing Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhaobing Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhaobing Ding more than expected).

Fields of papers citing papers by Zhaobing Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhaobing Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhaobing Ding. The network helps show where Zhaobing Ding may publish in the future.

Co-authorship network of co-authors of Zhaobing Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Zhaobing Ding. A scholar is included among the top collaborators of Zhaobing Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhaobing Ding. Zhaobing Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Sun-Yee, Qunxiang Ong, Yilie Liao, et al.. (2023). Genetic Ablation of LAT1 Inhibits Growth of Liver Cancer Cells and Downregulates mTORC1 Signaling. International Journal of Molecular Sciences. 24(11). 9171–9171. 8 indexed citations
2.
Ding, Zhaobing, Russell Ericksen, Qian Yi Lee, & Weiping Han. (2021). Reprogramming of mitochondrial proline metabolism promotes liver tumorigenesis. Amino Acids. 53(12). 1807–1815. 27 indexed citations
3.
Ding, Zhaobing, Russell Ericksen, Nathalie Escande‐Beillard, et al.. (2019). Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis. Journal of Hepatology. 72(4). 725–735. 87 indexed citations
4.
Ericksen, Russell, Siew Lan Lim, Eoin McDonnell, et al.. (2019). Loss of BCAA Catabolism during Carcinogenesis Enhances mTORC1 Activity and Promotes Tumor Development and Progression. Cell Metabolism. 29(5). 1151–1165.e6. 201 indexed citations
5.
Kim, Eung‐Sam, Animesh Samanta, Hui Cheng, et al.. (2015). Effect of oncogene activating mutations and kinase inhibitors on amino acid metabolism of human isogenic breast cancer cells. Molecular BioSystems. 11(12). 3378–3386. 5 indexed citations
6.
Ding, Zhaobing, Eung‐Sam Kim, Animesh Samanta, et al.. (2015). Abstract 1163: Phosphoserine aminotransferase 1 (PSAT1) as a novel anti-tumor target in hepatocellular carcinoma. Cancer Research. 75(15_Supplement). 1163–1163. 1 indexed citations
7.
Thöny, Beat, et al.. (2014). Phenotypic Reversion of Fair Hair upon Gene Therapy of the Phenylketonuria Mice. Human Gene Therapy. 25(7). 573–574. 3 indexed citations
8.
Ding, Zhaobing & Lang Zhuo. (2012). Attenuation of hepatic fibrosis by an imidazolium salt in thioacetamide‐induced mouse model. Journal of Gastroenterology and Hepatology. 28(1). 188–201. 17 indexed citations
9.
Ding, Zhaobing, et al.. (2011). An orally available small imidazolium salt ameliorates inflammation and fibrosis in a murine model of cholestasis. Laboratory Investigation. 91(5). 752–763. 11 indexed citations
10.
Zhang, Chunyan, et al.. (2009). A class of imidazolium salts is anti-oxidative and anti-fibrotic in hepatic stellate cells. Free Radical Research. 43(10). 899–912. 24 indexed citations
12.
Ding, Zhaobing, Gunter Maubach, Atsushi Masamune, & Zhuo Luan. (2008). Glial fibrillary acidic protein promoter targets pancreatic stellate cells. Digestive and Liver Disease. 41(3). 229–236. 17 indexed citations
13.
Ding, Zhaobing, et al.. (2008). Correction of Murine PKU Following AAV-mediated Intramuscular Expression of a Complete Phenylalanine Hydroxylating System. Molecular Therapy. 16(4). 673–681. 51 indexed citations
14.
Ding, Zhaobing, et al.. (2005). Stimulation of hepatic phenylalanine hydroxylase activity but not Pah-mRNA expression upon oral loading of tetrahydrobiopterin in normal mice. Molecular Genetics and Metabolism. 86. 153–155. 24 indexed citations
16.
Thöny, Beat, Zhaobing Ding, & Aurora Martı́nez. (2004). Tetrahydrobiopterin protects phenylalanine hydroxylase activity in vivo: Implications for tetrahydrobiopterin‐responsive hyperphenylalaninemia. FEBS Letters. 577(3). 507–511. 54 indexed citations
17.
Ding, Zhaobing, et al.. (2003). Sex‐peptides bind to two molecularly different targets in Drosophila melanogaster females. Journal of Neurobiology. 55(3). 372–384. 40 indexed citations
18.
Ding, Zhaobing. (2003). State-of-the-art 2003 on PKU gene therapy. Molecular Genetics and Metabolism. 81(1). 3–8. 36 indexed citations
19.
Saudan, Philippe, Matthias Soller, Yves Choffat, et al.. (2002). Ductus ejaculatorius peptide 99B (DUP99B), a novel Drosophila melanogaster sex‐peptide pheromone. European Journal of Biochemistry. 269(3). 989–997. 83 indexed citations
20.
Yang, Xiaolong, Y Hao, Zhaobing Ding, Alan Pater, & Shou Ching Tang. (1999). Differential expression of antiapoptotic gene BAG-1 in human breast normal and cancer cell lines and tissues.. PubMed. 5(7). 1816–22. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026